1. Home
  2. JCTC vs CTXR Comparison

JCTC vs CTXR Comparison

Compare JCTC & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCTC
  • CTXR
  • Stock Information
  • Founded
  • JCTC 1953
  • CTXR 2007
  • Country
  • JCTC United States
  • CTXR United States
  • Employees
  • JCTC N/A
  • CTXR N/A
  • Industry
  • JCTC
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCTC
  • CTXR Health Care
  • Exchange
  • JCTC NYSE
  • CTXR Nasdaq
  • Market Cap
  • JCTC 12.5M
  • CTXR 14.6M
  • IPO Year
  • JCTC 1996
  • CTXR N/A
  • Fundamental
  • Price
  • JCTC $3.78
  • CTXR $1.53
  • Analyst Decision
  • JCTC
  • CTXR Strong Buy
  • Analyst Count
  • JCTC 0
  • CTXR 3
  • Target Price
  • JCTC N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • JCTC 2.7K
  • CTXR 6.7M
  • Earning Date
  • JCTC 07-14-2025
  • CTXR 08-11-2025
  • Dividend Yield
  • JCTC N/A
  • CTXR N/A
  • EPS Growth
  • JCTC N/A
  • CTXR N/A
  • EPS
  • JCTC N/A
  • CTXR N/A
  • Revenue
  • JCTC $47,432,094.00
  • CTXR N/A
  • Revenue This Year
  • JCTC N/A
  • CTXR N/A
  • Revenue Next Year
  • JCTC N/A
  • CTXR N/A
  • P/E Ratio
  • JCTC N/A
  • CTXR N/A
  • Revenue Growth
  • JCTC N/A
  • CTXR N/A
  • 52 Week Low
  • JCTC $3.26
  • CTXR $0.65
  • 52 Week High
  • JCTC $5.41
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • JCTC N/A
  • CTXR 68.44
  • Support Level
  • JCTC N/A
  • CTXR $0.76
  • Resistance Level
  • JCTC N/A
  • CTXR $1.45
  • Average True Range (ATR)
  • JCTC 0.00
  • CTXR 0.31
  • MACD
  • JCTC 0.00
  • CTXR 0.06
  • Stochastic Oscillator
  • JCTC 0.00
  • CTXR 47.63

About JCTC JEWETT-CAMERON TRADING CO

Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: